Our present observations on the therapeutic effect of IL-4Rα blockade in murine experimental conjunctivitis are inconsistent with the increased frequency of conjunctivitis following treatment with dupilumab in patients with AD. The gene discussed is IL4R; the disease is conjunctivitis.